Irvine, CA, United States of America

Paolo Piatti

This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Zymo Research Corporation. Active years: 2020.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Paolo Piatti

Introduction

Paolo Piatti is a notable inventor based in Irvine, California. He has made significant contributions to the field of genomics, particularly in the area of cancer research. His work focuses on developing methods to assess DNA methylation, which plays a crucial role in understanding various cancers.

Latest Patents

Paolo Piatti holds a patent for "Assays to determine DNA methylation and DNA methylation markers of cancer." This patent outlines methods for determining a genomic methylation profile in a DNA sample. The methods can be utilized to assess whether a subject has, or is at risk for developing, bladder cancer or other cancers of the urinary tract. Additionally, the patent provides methods for the treatment of such subjects.

Career Highlights

Paolo Piatti is associated with Zymo Research Corporation, where he applies his expertise in molecular biology and cancer research. His innovative approaches have contributed to advancements in the understanding of cancer biomarkers and potential therapeutic strategies.

Collaborations

Paolo has collaborated with esteemed colleagues such as Wei Guo and Xiaojing Yang, enhancing the research efforts at Zymo Research Corporation.

Conclusion

In summary, Paolo Piatti's work in DNA methylation and cancer research exemplifies the impact of innovative thinking in the scientific community. His contributions continue to pave the way for advancements in cancer diagnostics and treatment.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…